IntuitionLabs is now a member of the Claude Partner Network – AI training and upskilling with Claude for pharma and biotech. Book a call.
A July 2026 comparison of Claude Science, GPT-Rosalind, and Isomorphic Labs covering pricing, access models, published benchmarks, named enterprise adoption, and which platform fits which life-sciences use case.
An in-depth analysis of Isomorphic Labs' $2.1B Series B funding. Examine the IsoDDE AI drug design engine, AlphaFold's role, and biotech industry impacts.
Examine the 2026 landscape of AI biologics discovery. This analysis details protein modeling, generative design, and key pharma R&D investment trends.
Explore the exponential rise in AI compute demand in biotech. This 2025 report analyzes key statistics, infrastructure needs, and trends in drug discovery and g
How AI leaders like Amodei, Hassabis, and Huang are accelerating drug discovery, genomics, and life science breakthroughs—compressing decades into years. Updated January 2026 with AlphaFold 3, Claude for Life Sciences, NVIDIA Evo 2, and $3B+ pharma partnerships.
© 2026 IntuitionLabs. All rights reserved.
